Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The airway epithelial cell membrane is the boundary structure of airway epithelial cells in the respiratory tract, consisting of a phospholipid bilayer embedded with proteins, glycoproteins, and receptors. It underlies the critical barrier function of the airway epithelium, regulating permeability, preventing pathogen entry, participating in mucosal defense, and enabling selective transport and signaling. The membrane’s molecular complexes—tight junctions, adherens junctions, and associated cytoskeletal networks—ensure structural integrity and homeostasis. Disruption or dysfunction of this membrane contributes to airway diseases such as asthma, COPD, and cystic fibrosis via impaired barrier function, enhanced inflammation, and reduced antimicrobial defense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway epithelial cell membrane.